GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $42,544,000 | +7538.1% | 1,780,068 | +4562.9% | 0.03% | – |
| Q4 2020 | $557,000 | -95.8% | 38,175 | -95.9% | 0.00% | -100.0% |
| Q3 2020 | $13,113,000 | -58.2% | 923,485 | -56.7% | 0.02% | -62.8% |
| Q2 2020 | $31,384,000 | +779.3% | 2,133,522 | +146.3% | 0.04% | +437.5% |
| Q1 2020 | $3,569,000 | +574.7% | 866,382 | +687.2% | 0.01% | +700.0% |
| Q4 2019 | $529,000 | -80.5% | 110,060 | -75.4% | 0.00% | -75.0% |
| Q3 2019 | $2,713,000 | -23.6% | 447,721 | -18.2% | 0.00% | -20.0% |
| Q2 2019 | $3,552,000 | +8.1% | 547,263 | +18.0% | 0.01% | 0.0% |
| Q1 2019 | $3,287,000 | +1436.0% | 463,667 | +955.0% | 0.01% | – |
| Q4 2018 | $214,000 | -95.4% | 43,948 | -93.0% | 0.00% | -100.0% |
| Q3 2018 | $4,641,000 | -1.9% | 631,444 | -14.9% | 0.01% | 0.0% |
| Q2 2018 | $4,732,000 | +1329.6% | 741,752 | +1118.6% | 0.01% | – |
| Q1 2018 | $331,000 | -86.9% | 60,870 | -89.9% | 0.00% | -100.0% |
| Q4 2017 | $2,519,000 | -82.2% | 604,087 | -58.9% | 0.00% | -86.4% |
| Q3 2017 | $14,151,000 | +1.4% | 1,469,434 | +24.6% | 0.02% | -12.0% |
| Q2 2017 | $13,949,000 | +23.5% | 1,179,091 | +33.8% | 0.02% | +19.0% |
| Q1 2017 | $11,294,000 | +5.0% | 880,939 | +0.3% | 0.02% | -8.7% |
| Q4 2016 | $10,752,000 | +63.6% | 878,415 | +57.7% | 0.02% | +109.1% |
| Q3 2016 | $6,572,000 | +1867.7% | 556,938 | +1195.5% | 0.01% | +1000.0% |
| Q4 2015 | $334,000 | -73.0% | 42,991 | -72.7% | 0.00% | -50.0% |
| Q3 2015 | $1,239,000 | -20.1% | 157,382 | -8.0% | 0.00% | -33.3% |
| Q2 2015 | $1,550,000 | -67.6% | 171,033 | -53.7% | 0.00% | -66.7% |
| Q1 2015 | $4,790,000 | -27.1% | 369,026 | -23.6% | 0.01% | -35.7% |
| Q4 2014 | $6,575,000 | +89.5% | 483,105 | +24.9% | 0.01% | +55.6% |
| Q3 2014 | $3,470,000 | +248.7% | 386,891 | +426.0% | 0.01% | +200.0% |
| Q2 2014 | $995,000 | -68.5% | 73,552 | -76.8% | 0.00% | -66.7% |
| Q1 2014 | $3,156,000 | +850.6% | 317,482 | +1169.9% | 0.01% | +800.0% |
| Q4 2013 | $332,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |